Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
XBI
139
HOLDINGS
25%
ALSO IN CANC
CANC
56
HOLDINGS
61%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
HALOZYME THERAPEUTICS INC | 1.6% | 1.6% | 1.6% |
|
REVOLUTION MEDICINES, INC. | 1.5% | 6.2% | 1.5% |
|
AMGEN INC | 1.5% | 2.5% | 1.5% |
|
EXELIXIS INC | 1.3% | 2.3% | 1.3% |
|
CELCUITY INC. | 1.3% | 2.4% | 1.3% |
XBI Overweight Relative to CANC
|
MODERNA, INC. | 1.7% |
|
VAXCYTE, INC. | 1.6% |
 |
ROIVANT SCIENCES LTD. | 1.5% |
|
MIRUM PHARMACEUTICALS, INC. | 1.5% |
 |
ALKERMES PLC | 1.5% |
|
AMICUS THERAPEUTICS INC | 1.5% |
|
INCYTE CORP | 1.4% |
|
KRYSTAL BIOTECH, INC. | 1.4% |
|
BIOGEN IDEC INC | 1.4% |
|
IONIS PHARMACEUTICALS, INC. | 1.3% |
XBI Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -4.7% |
 |
NOVARTIS AG | -4.6% |
|
ELI LILLY & CO | -4.5% |
|
ASTRAZENECA PLC | -4.4% |
|
BRISTOL-MYERS SQUIBB CO | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
MERCK & CO. INC. | -3.9% |
|
BRIDGEBIO PHARMA, INC. | -3.4% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
|
JOHNSON & JOHNSON | -2.5% |